Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all.
作者信息
Newman Lisa A, Roff Nathalie Kim, Weinberg Armin D
出版信息
Ann Surg Oncol. 2008 Jul;15(7):1818-9. doi: 10.1245/s10434-008-9869-2. Epub 2008 Apr 19.
Abstract
摘要
相似文献
1
Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all.癌症临床试验入组：解决差异方面错失的机会以及改善所有人治疗结果方面错失的机会。
Ann Surg Oncol. 2008 Jul;15(7):1818-9. doi: 10.1245/s10434-008-9869-2. Epub 2008 Apr 19.
2
An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual.增强少数群体参与癌症临床试验（EMPaCT）概述及影响少数群体参与癌症临床试验的基本问题：增强少数群体参与临床试验（EMPaCT）：为改善少数群体临床试验入组奠定基础。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1087-90. doi: 10.1002/cncr.28569.
3
An institutional strategy to increase minority recruitment to therapeutic trials.一项增加少数民族参与治疗性试验的机构策略。
Cancer Causes Control. 2013 Oct;24(10):1797-809. doi: 10.1007/s10552-013-0258-1. Epub 2013 Jul 12.
4
Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.以少数族裔入组为重点，提高癌症临床试验的入组率：威廉博蒙特医院社区临床肿瘤学项目的经验。
Cancer. 2011 Oct 15;117(20):4764-71. doi: 10.1002/cncr.26094. Epub 2011 Mar 31.
5
Participation in cancer trials: recruitment of underserved populations.参与癌症试验：招募服务不足人群。
Clin Adv Hematol Oncol. 2003 Oct;1(10):607-13.
6
Racial and ethnic health disparities in healthcare settings.医疗环境中的种族和民族健康差异。
BMJ. 2021 Mar 8;372:n605. doi: 10.1136/bmj.n605.
7
Policies to address disparities in clinical trials: the EDICT Project.解决临床试验差异的政策：EDICT项目。
J Cancer Educ. 2009;24(2 Suppl):S39-49. doi: 10.1007/BF03182311.
8
Disparities in participation in cancer clinical trials.癌症临床试验参与方面的差异。
JAMA. 2004 Aug 25;292(8):922; author reply 922-3. doi: 10.1001/jama.292.8.922-a.
9
Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.减少少数群体的癌症差异：一项多学科研究议程，旨在改善患者获得医疗系统、临床试验和有效癌症治疗的机会。
J Clin Oncol. 2006 May 10;24(14):2209-15. doi: 10.1200/JCO.2005.04.8116.
10
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study.确定并克服少数族裔人群参与临床试验的障碍：从 VanDAAM 研究中吸取的经验教训。
Cancer Med. 2023 Jan;12(2):1869-1877. doi: 10.1002/cam4.5000. Epub 2022 Jul 7.
引用本文的文献
1
Breast Cancer Disparities and the COVID-19 Pandemic.乳腺癌差异与新冠疫情
Curr Breast Cancer Rep. 2022;14(4):192-198. doi: 10.1007/s12609-022-00458-y. Epub 2022 Aug 30.
2
Health Disparities in Recruitment and Enrollment in Research.健康差异在研究招募和参与中。
Thorac Surg Clin. 2022 Feb;32(1):75-82. doi: 10.1016/j.thorsurg.2021.09.012.
3
Cancer Disparities and Black American Representation in Clinical Trials Leading to the Approval of Oral Chemotherapy Drugs in the United States Between 2009 and 2019.2009 年至 2019 年期间，美国批准的口服化疗药物相关临床试验中癌症差异和非裔美国人代表性研究。
JCO Oncol Pract. 2021 May;17(5):e623-e628. doi: 10.1200/OP.20.01108.
4
Racial and ethnic representation in epigenomic studies of preterm birth: a systematic review.种族和民族在早产的表观基因组研究中的代表性：系统综述。
Epigenomics. 2021 Nov;13(21):1735-1746. doi: 10.2217/epi-2020-0007. Epub 2020 Dec 2.
5
Race/Ethnicity and County-Level Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery.种族/族裔与县级社会脆弱性对接受癌症手术患者临终关怀利用情况的影响。
Ann Surg Oncol. 2021 Apr;28(4):1918-1926. doi: 10.1245/s10434-020-09227-6. Epub 2020 Oct 14.
6
Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations.新冠疫情对临床研究和多样化人群纳入的影响。
Ethn Dis. 2020 Jul 9;30(3):429-432. doi: 10.18865/ed.30.3.429. eCollection 2020 Summer.
7
Project PLACE: Enhancing community and academic partnerships to describe and address health disparities.PLACE 项目：加强社区和学术伙伴关系，以描述和解决健康差距问题。
Adv Cancer Res. 2020;146:167-188. doi: 10.1016/bs.acr.2020.01.009. Epub 2020 Mar 19.
8
Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.与三个美国国家癌症研究所指定癌症中心的社区样本中参与生物医学研究相关的因素。
Cancer. 2020 Mar 1;126(5):1077-1089. doi: 10.1002/cncr.32487. Epub 2020 Jan 7.
9
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.癌症临床试验合作（PACCT）：一项增加前列腺癌临床试验中少数族裔参与率的患者与医生沟通干预随机试验的研究方案。
BMC Cancer. 2017 Dec 2;17(1):807. doi: 10.1186/s12885-017-3804-5.
10
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.癌症种族和少数民族患者临床试验入组的障碍
Cancer Control. 2016 Oct;23(4):327-337. doi: 10.1177/107327481602300404.
本文引用的文献
1
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.参与外科肿瘤学临床试验：基于性别、种族/民族和年龄的差异。
Ann Surg Oncol. 2007 Dec;14(12):3328-34. doi: 10.1245/s10434-007-9500-y. Epub 2007 Aug 8.
2
Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.利用国家癌症数据库制定适合少数族裔患者的临床试验入组目标：美国外科医师肿瘤学组（ACOSOG）特殊人群委员会的报告
Cancer. 2006 Jan 1;106(1):188-95. doi: 10.1002/cncr.21592.
Zotero 插件